Cleavage of Abasic Sites in DNA by an Aminoquinoxaline Compound: Augmented Cytotoxicity and DNA Damage in Combination with an Anticancer Drug Chlorambucil in Human Colorectal Carcinoma Cells
Authors:
Open Access
- 18 February 2022
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 7 (8) , 6488-6501
Abstract
The elevated level of endogenous oxidative DNA damage and spontaneous deamination of DNA bases in cancer cells substantially increase the abasic sites in DNA via base excision repairs (BERs). Thus, the predominant BER pathway is a favorable target for cancer therapy. Interestingly, elevated levels of glutathione (GSH) in certain cancer cells, such as colon cancer, are associated with acquired resistance to several chemotherapeutic agents, which increase the difficulty for the treatment of cancer. Here, we have reported an ideal nitro group-containing monoquinoxaline DNA intercalator (1d), which is reduced into a fluorescent quinoxaline amine (1e) in the presence of GSH; concurrently, 1e (∼100 nM concentration) selectively causes the in vitro cleavage of abasic sites in DNA. 1e also binds to the tetrahydrofuran analogue of the abasic site in the nanomolar to low micromolar range depending on the nucleotide sequence opposite to the abasic site and also induces a structural change in abasic DNA. Furthermore, the amine compound (1e) augments the response of the specific bifunctional alkylating drug chlorambucil at a much lower concentration in the human colorectal carcinoma cell (HCT-116), and their combination shows a potential strategy for targeted therapy. Alone or in combination, 1d and 1e lead to a cascade of cellular events such as induction of DNA double-stranded breaks and cell arrest at G0/G1 and G2/M phases, eventually leading to apoptotic cell death in HCT-116 cells. Hence, the outcome of this study provides a definitive approach that will help optimize the therapeutic applications for targeting the abasic site in cancer cells.Keywords
Funding Information
- Council of Scientific and Industrial Research, India (MLP-139)
- University Grants Commission
- Anusandhan National Research Foundation (EMR/2017/000659)
This publication has 58 references indexed in Scilit:
- Mechanistic Studies on Histone Catalyzed Cleavage of Apyrimidinic/Apurinic Sites in Nucleosome Core ParticlesJournal of the American Chemical Society, 2012
- Small-Molecule Inhibitors of DNA Damage-Repair Pathways: An Approach to Overcome Tumor Resistance to Alkylating Anticancer DrugsFuture Medicinal Chemistry, 2012
- DNA Damage Induced by Alkylating Agents and Repair PathwaysJournal of Nucleic Acids, 2010
- An Overview of Chemical Processes That Damage Cellular DNA: Spontaneous Hydrolysis, Alkylation, and Reactions with RadicalsChemical Research in Toxicology, 2009
- -H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatinNucleic Acids Research, 2008
- γH2AX Foci Form Preferentially in Euchromatin after Ionising-RadiationPLOS ONE, 2007
- Targeting DNA repair as a promising approach in cancer therapyEuropean Journal of Cancer, 2007
- Interstrand Cross-Links Generated by Abasic Sites in Duplex DNAJournal of the American Chemical Society, 2007
- DNA damage response as a candidate anti-cancer barrier in early human tumorigenesisNature, 2005
- Efficient breakage of DNA apurinic sites by the indole-amine related 9-amino-ellipticineChemico-Biological Interactions, 1986